Search
Tenecteplase Action Pathway (new)
smpdb.ca/view/SMP0126640Drug actionTenecteplase is a plasminogen activator, a modified form of recombinant human tissue, also known as Metalyse and Tnkase, used in emergencies such as myocardial infarction and pulmonary emboli. … Due to its anticoagulant and antiplatelet activity herbs and supplements with similar activity should be avoided such as garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba.
Enzymes: Coagulation factor IX, Coagulation factor VIIITuroctocog Alfa Action Pathway
smpdb.ca/view/SMP0126775Drug actionIt is administered intravenously and acts similarly to coagulation factor VIII, forming a complex with IX in order to activate factor X leading to a blood clot forming. … Turoctocog alfa allows the missing factor coagulation VIII to be replaced and restore blood clotting.
Enzymes: Coagulation factor IX, Coagulation factor VIIIEmicizumab Action Pathway
smpdb.ca/view/SMP0126843Drug actionEmicizumab also known as Hemlibra, is a humanized recombinant monoclonal antibody that mimics coagulation factor VIII and can bind to activated coagulation factor IX and X. … Emicizumab performs the function of coagulation factor VIII, with the ability to also bind to both coagulation factor IX and X.
Enzymes: Coagulation factor IX, Coagulation factor VIIITuroctocog Alfa Pegol Action Pathway
smpdb.ca/view/SMP0126856Drug actionIt acts by replacing coagulation factor VIII which is deficient in patients with hemophilia. … The difference between turoctocog alfa pegol and turoctocog alfa is the modification to the structure of turoctocog alfa pegol extends its half-life.
Enzymes: Coagulation factor IX, Coagulation factor VIIIDabigatran Etexilate Action Pathway
smpdb.ca/view/SMP0126433Drug actionThis drug does interact with food, herbs and supplements with anticoagulant and antiplatelet activity should be avoided such as garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba. St. … Dabigatran competitively binds and inhibits thrombin by doing so stops the formation of fibrin and therefore the meshwork for a thrombus.
Enzymes: Coagulation factor IX, Coagulation factor VIIIBetrixaban Action Pathway
smpdb.ca/view/SMP0126432Drug actionDue to its interaction with factor Xa, the coagulant factor is no longer free and unable to form the prothrombinase complex. … Betrixaban is an anticoagulant that targets and inhibits factor Xa in order to prevent venous thromboembolism.
Drugs: CalciumEnzymes: Coagulation factor IX, Coagulation factor VIIIRivaroxaban Action Pathway
smpdb.ca/view/SMP0126439Drug actionRivaroxaban is an anticoagulant that inhibits coagulation factor X, typically used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). … Rivaroxaban competitively inhibits free and clot-bound factor X. Coagulation factor X makes up a part of the prothrombinase complex that is responsible for the conversion of prothrombin to thrombin.
Drugs: CalciumEnzymes: Coagulation factor IX, Coagulation factor VIIIReteplase Action Pathway (new)
smpdb.ca/view/SMP0126637Drug actionReteplase is a plasminogen activator that is created as a purified form of human tissue, also known as Retavase that is used in emergencies such as myocardial infarction, ischemic stroke and pulmonary … Reteplase is administered intravenously and travels through the bloodstream and acts on plasminogen cleaving an arginine-valine bond converting it to its active form plasmin.
Enzymes: Coagulation factor IX, Coagulation factor VIIIStreptokinase Action Pathway (new)
smpdb.ca/view/SMP0126642Drug actionDue to the anticoagulant and antiplatelet activity, herbs and supplements with a similar activity should be avoided such as garlic, ginger, bilberry, danshen, piracetam and ginkgo biloba. … Streptokinase is a bacterial protein that is fibrinolytic and used to break down blood clots in myocardial infarction, pulmonary embolism and venous thromboembolism.
Enzymes: Coagulation factor IX, Coagulation factor VIIILonoctocog Alfa Action Pathway
smpdb.ca/view/SMP0126848Drug actionLonoctocog alfa also known as Afstyla is a recombinant coagulation factor VIII that is used in the treatment of hemophilia A. … Once administered intravenously it binds to the coagulation factor IXa to convert coagulation factor X to its active form Xa to carry on the reactions of the clotting cascade.
Enzymes: Coagulation factor IX, Coagulation factor VIII